ESCMID*  	ESCMID*  	 NNP	B-NP
guideline  	guideline  	 NN	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
diagnosis  	diagnosis  	 NN	O
and  	and  	 CC	O
management  	management  	 NN	O
of  	of  	 IN	O
Candida  	Candida  	 NNP	B-NP
diseases  	diseases  	 VBD	I-NP
2012 	2012 	 CD	O
:  	:  	 :	O
developing  	developing  	 VBG	O
European  	European  	 JJ	O
guidelines  	guidelines  	 NNS	O
in  	in  	 IN	O
clinical  	clinical  	 JJ	B-NP
microbiology  	microbiology  	 NN	I-NP
and  	and  	 CC	O
infectious  	infectious  	 JJ	B-NP
diseases  	diseases  	 NNS	I-NP
The  	The  	 DT	O
process  	process  	 NN	O
to  	to  	 TO	O
develop  	develop  	 VB	O
a  	a  	 DT	O
guideline  	guideline  	 NN	O
in  	in  	 IN	O
a  	a  	 DT	O
European  	European  	 JJ	O
setting  	setting  	 NN	O
remains  	remains  	 VBZ	O
a  	a  	 DT	O
challenge 	challenge 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
ESCMID  	ESCMID  	 NNP	O
Fungal  	Fungal  	 NNP	O
Infection  	Infection  	 NNP	O
Study  	Study  	 NNP	O
Group  	Group  	 NNP	O
( 	( 	 -LRB-	O
EFISG 	EFISG 	 NNP	B-NP
)  	)  	 -RRB-	O
successfully  	successfully  	 RB	O
achieved  	achieved  	 VBN	O
this  	this  	 DT	O
endeavour 	endeavour 	 NN	O
.  	.  	 .	O
After  	After  	 IN	O
two  	two  	 CD	O
face-to-face  	face-to-face  	 JJ	B-NP
meetings 	meetings 	 NNS	I-NP
,  	,  	 ,	O
numerous  	numerous  	 JJ	B-NP
telephone  	telephone  	 NN	I-NP
conferences 	conferences 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
email  	email  	 JJ	B-NP
correspondence 	correspondence 	 NN	I-NP
,  	,  	 ,	O
an  	an  	 DT	O
ESCMID  	ESCMID  	 NNP	B-NP
task  	task  	 NN	I-NP
force  	force  	 NN	I-NP
( 	( 	 -LRB-	O
basically  	basically  	 RB	O
composed  	composed  	 VBN	O
of  	of  	 IN	O
members  	members  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
Society 	Society 	 NNP	O
's  	's  	 POS	O
Fungal  	Fungal  	 NNP	O
Infection  	Infection  	 NNP	O
Study  	Study  	 NNP	O
Group 	Group 	 NNP	O
,  	,  	 ,	O
EFISG 	EFISG 	 NNP	B-NP
)  	)  	 -RRB-	O
finalized  	finalized  	 VBD	O
the  	the  	 DT	O
ESCMID  	ESCMID  	 NNP	B-NP
diagnostic  	diagnostic  	 JJ	I-NP
and  	and  	 CC	O
management 	management 	 NN	B-NP
/ 	/ 	 CD	I-NP
therapeutic  	therapeutic  	 JJ	I-NP
guideline  	guideline  	 NN	I-NP
for  	for  	 IN	I-NP
Candida  	Candida  	 NNP	I-NP
diseases 	diseases 	 NNS	I-NP
.  	.  	 .	O
By  	By  	 IN	O
appreciating  	appreciating  	 VBG	O
various  	various  	 JJ	O
patient  	patient  	 NN	O
populations  	populations  	 NNS	O
at  	at  	 IN	O
risk  	risk  	 NN	O
for  	for  	 IN	O
Candida  	Candida  	 NNP	B-NP
diseases 	diseases 	 NNS	I-NP
,  	,  	 ,	O
four  	four  	 CD	O
subgroups  	subgroups  	 NNS	B-NP
were  	were  	 VBD	O
predefined 	predefined 	 CD	O
,  	,  	 ,	O
mainly  	mainly  	 RB	O
ICU  	ICU  	 JJ	B-NP
patients 	patients 	 NNS	I-NP
,  	,  	 ,	O
paediatric 	paediatric 	 NN	B-NP
,  	,  	 ,	O
HIV 	HIV 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
AIDS  	AIDS  	 NNP	I-NP
and  	and  	 CC	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
malignancies  	malignancies  	 NNS	O
including  	including  	 VBG	O
haematopoietic  	haematopoietic  	 JJ	B-NP
stem  	stem  	 NN	I-NP
cell  	cell  	 NN	I-NP
transplantation 	transplantation 	 NN	I-NP
.  	.  	 .	O
Besides  	Besides  	 IN	O
treatment  	treatment  	 NN	B-NP
recommendations 	recommendations 	 NNS	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
ESCMID  	ESCMID  	 NNP	B-NP
guidelines  	guidelines  	 NNS	I-NP
provide  	provide  	 VBP	O
guidance  	guidance  	 VBN	O
for  	for  	 IN	O
diagnostic  	diagnostic  	 JJ	B-NP
procedures 	procedures 	 NNS	I-NP
.  	.  	 .	O
For  	For  	 IN	O
the  	the  	 DT	O
guidelines 	guidelines 	 NNS	O
,  	,  	 ,	O
questions  	questions  	 NNS	O
were  	were  	 VBD	O
formulated  	formulated  	 VBN	O
to  	to  	 TO	O
phrase  	phrase  	 VB	O
the  	the  	 DT	O
intention  	intention  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
given  	given  	 VBN	O
recommendation 	recommendation 	 NN	B-NP
,  	,  	 ,	O
for  	for  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
outcome 	outcome 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
recommendation  	recommendation  	 NN	B-NP
was  	was  	 VBD	O
the  	the  	 DT	O
clinical  	clinical  	 JJ	B-NP
intervention 	intervention 	 NN	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
was  	was  	 VBD	O
graded  	graded  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
score  	score  	 NN	O
of  	of  	 IN	O
A-D  	A-D  	 NNP	B-NP
for  	for  	 IN	O
the  	the  	 DT	O
' 	' 	 POS	O
Strength  	Strength  	 NNP	O
of  	of  	 IN	O
a  	a  	 DT	O
recommendation 	recommendation 	 NN	B-NP
' 	' 	 POS	O
.  	.  	 .	O
The  	The  	 NNP	O
' 	' 	 POS	O
level  	level  	 NN	O
of  	of  	 IN	O
evidence 	evidence 	 NN	O
'  	'  	 POS	O
received  	received  	 VBD	O
a  	a  	 DT	O
score  	score  	 NN	O
of  	of  	 IN	O
I-III 	I-III 	 JJ	B-NP
.  	.  	 .	O
The  	The  	 DT	O
author  	author  	 NN	B-NP
panel  	panel  	 NN	I-NP
was  	was  	 VBD	O
approved  	approved  	 VBN	O
by  	by  	 IN	O
ESCMID 	ESCMID 	 NNP	B-NP
,  	,  	 ,	O
European  	European  	 NNP	O
Organisation  	Organisation  	 NNP	B-NP
for  	for  	 IN	O
Research  	Research  	 NNP	O
and  	and  	 CC	O
Treatment  	Treatment  	 NNP	O
of  	of  	 IN	O
Cancer 	Cancer 	 NNP	O
,  	,  	 ,	O
European  	European  	 NNP	O
Group  	Group  	 NNP	O
for  	for  	 IN	O
Blood  	Blood  	 NNP	O
and  	and  	 CC	O
Marrow  	Marrow  	 NNP	B-NP
Transplantation 	Transplantation 	 NNP	I-NP
,  	,  	 ,	O
European  	European  	 NNP	O
Society  	Society  	 NNP	O
of  	of  	 IN	O
Intensive  	Intensive  	 NNP	B-NP
Care  	Care  	 NNP	I-NP
Medicine  	Medicine  	 NNP	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
European  	European  	 NNP	O
Confederation  	Confederation  	 NNP	B-NP
of  	of  	 IN	I-NP
Medical  	Medical  	 NNP	I-NP
Mycology 	Mycology 	 NNP	I-NP
.  	.  	 .	O
The  	The  	 DT	O
guidelines  	guidelines  	 NNS	O
followed  	followed  	 VBD	O
the  	the  	 DT	O
framework  	framework  	 NN	O
of  	of  	 IN	O
GRADE  	GRADE  	 NNP	O
and  	and  	 CC	O
Appraisal  	Appraisal  	 NNP	O
of  	of  	 IN	O
Guidelines 	Guidelines 	 NNP	O
,  	,  	 ,	O
Research 	Research 	 NNP	O
,  	,  	 ,	O
and  	and  	 CC	O
Evaluation 	Evaluation 	 NNP	O
.  	.  	 .	O
The  	The  	 DT	O
drafted  	drafted  	 JJ	O
guideline  	guideline  	 NN	O
was  	was  	 VBD	O
presented  	presented  	 VBN	O
at  	at  	 IN	O
ECCMID  	ECCMID  	 NNP	B-NP
2011  	2011  	 CD	O
and  	and  	 CC	O
points  	points  	 NNS	O
of  	of  	 IN	O
discussion  	discussion  	 NN	O
occurring  	occurring  	 VBG	O
during  	during  	 IN	O
that  	that  	 DT	O
meeting  	meeting  	 NN	O
were  	were  	 VBD	O
incorporated  	incorporated  	 VBN	O
into  	into  	 IN	O
the  	the  	 DT	O
manuscripts 	manuscripts 	 NN	O
.  	.  	 .	O
These  	These  	 DT	O
ESCMID  	ESCMID  	 NNP	B-NP
guidelines  	guidelines  	 NNS	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
diagnosis  	diagnosis  	 NN	O
and  	and  	 CC	O
management  	management  	 NN	O
of  	of  	 IN	O
Candida  	Candida  	 NNP	B-NP
diseases  	diseases  	 NNS	I-NP
provide  	provide  	 VBP	O
guidance  	guidance  	 VBN	O
for  	for  	 IN	O
clinicians  	clinicians  	 NN	B-NP
in  	in  	 IN	O
their  	their  	 PRP$	O
daily  	daily  	 JJ	O
decision-making  	decision-making  	 JJ	B-NP
process 	process 	 NN	I-NP
.  	.  	 .	O
